ℹ️
🇨🇿
Hledání
Hledat publikace relevantní k dotazu "Clostridioides difficile infection"
Clostridioides difficile infection
Publikace
Předměty
Osoby
Publikace
Studium
Exportovat aktuální pohled
publication
Update on Microbiota-derived therapies for recurrent Clostridioides difficile infections, 2023
2024 |
2. lékařská fakulta
publication
Aktualizovaný doporučený postup pro léčbu nemocných s kolitidou vyvolanou Clostridioides difficile
2022 |
2. lékařská fakulta, 3. lékařská fakulta
publication
Mortality following clostridioides difficile infection in Europe: A retrospective multicenter case-control study
2021 |
2. lékařská fakulta
publication
Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?
2022 |
2. lékařská fakulta
publication
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
2021 |
Publikace bez příslušnosti k fakultě
publication
How to: Clostridioides difficile infection in children
2022 |
Publikace bez příslušnosti k fakultě
publication
Hear My Voice: involving patients in Clostridioides difficile infection research
2023 |
2. lékařská fakulta
publication
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
2023 |
2. lékařská fakulta
publication
Infekce vyvolané Clostridioides difficile u dětských pacientů Fakultní nemocnice v Motole
2022 |
2. lékařská fakulta
publication
Re: 'the effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al
2024 |
2. lékařská fakulta
publication
Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové
2021 |
3. lékařská fakulta, Lékařská fakulta v Hradci Králové
publication
Strong Antimicrobial Effects of Xanthohumol and Beta-Acids from Hops against Clostridioides difficile Infection In Vivo
+1
2021 |
Lékařská fakulta v Hradci Králové
publication
Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection-an observational cohort study
2021 |
2. lékařská fakulta, 3. lékařská fakulta
publication
Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018-2019
2023 |
2. lékařská fakulta
publication
An Outbreak of Clostridium (Clostridioides) difficile Infections within an Acute and Long-Term Care Wards Due to Moxifloxacin-Resistant PCR Ribotype 176 Genotyped as PCR Ribotype 027 by a Commercial Assay
2020 |
2. lékařská fakulta
publication
Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members
2024 |
2. lékařská fakulta
publication
Clostridium difficile a současné pohledy na léčbu a prevenci
2020 |
Lékařská fakulta v Hradci Králové
publication
Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT
2023 |
Publikace bez příslušnosti k fakultě
publication
The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients
2020 |
2. lékařská fakulta
publication
2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients
2019 |
1. lékařská fakulta
publication
Fekální mikrobiální terapie - tajemná metoda, nebo východisko budoucích léčebných modulací střevní mikrobioty?
2021 |
3. lékařská fakulta
publication
Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review
2022 |
2. lékařská fakulta
publication
Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
2020 |
2. lékařská fakulta
publication
Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors
2022 |
2. lékařská fakulta, 3. lékařská fakulta, Matematicko-fyzikální fakulta